PATENT CLAIM ANALYSIS

Application Number: 16096778
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-06
Patent Classification: ["546", "223000"]

Abstract:
A cyclohexene derivative or pharmaceutically acceptable salt thereof and application thereof, which belongs to the technical field of pharmaceutical technology is provided. The cyclohexene derivative of formula I or pharmaceutically acceptable salt thereof is a new broad-spectrum anti-influenza compound, having a great inhibiting effect on influenza viruses, specifically, it has a high activity to virus strains which is drug-resistant to Oseltamivir, and may be used as a broad-spectrum anti-influenza NA inhibitor effective to Tamiflu drug-resistance, for treating the flu caused by influenza viruses, thereby it is a broad-spectrum anti-influenza drug.

Claim (Index 5):
The injectable formulation of anti-influenza virus according to  claim 2 , wherein the injectable formulation is a sterile powder for injection and the sterile powder further comprises a pharmaceutically acceptable excipient.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 99.0
- Lexical Diversity: 1.57143
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13697794', '14779279', '14118768', '16062253', '13836356']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6319437257683527
- 35 USC 102 Novelty (BERT): 0.5050140004081265
- Combined Prediction Score: 0.61925075323233
- Mean Citation Score: 242.371644
- Max Citation Score: 254.91457000000003
- Similarity Product: 194.87891243246915

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test